Published in J Gen Virol on April 01, 1983
Construction and characterization of two infectious molecular clones of encephalomyocarditis virus. J Virol (1990) 0.99
An apparent deletion of an oligonucleotide detected by RNA fingerprint in the nondiabetogenic B variant of encephalomyocarditis virus is caused by a point mutation. J Virol (1988) 0.85
Picornavirus infection leading to immunosuppression. Future Virol (2014) 0.78
Role of brain insulin receptor in control of body weight and reproduction. Science (2000) 8.14
The characterization of soluble amyloid prepared in water. J Clin Invest (1968) 6.17
Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med (1979) 5.58
Polyadenylation sites for influenza virus mRNA. J Virol (1981) 4.42
Effect of virus infections on the function of the immune system. Annu Rev Microbiol (1970) 4.30
Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature (1985) 3.62
Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med (1979) 3.62
Primary structure of the vesicular stomatitis virus polymerase (L) gene: evidence for a high frequency of mutations. J Virol (1984) 3.54
The origins of defective interfering particles of the negative-strand RNA viruses. Cell (1981) 3.50
Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet (1988) 3.46
NCI-Navy Medical Oncology Branch cell line data base. J Cell Biochem Suppl (1996) 3.24
Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc Natl Acad Sci U S A (1996) 3.07
CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today (1989) 2.96
Thymus dependence of viral antigens. Nature (1975) 2.95
Heterogeneity in the properties of 7 S and 19S rabbit-neutralizing antibodies to herpes simplex virus. J Immunol (1968) 2.90
Nucleotide sequence homology at the 3' termini of RNA from vesicular stomatitis virus and its defective interfering particles. Proc Natl Acad Sci U S A (1978) 2.82
Site on the vesicular stomatitis virus genome specifying polyadenylation and the end of the L gene mRNA. J Virol (1980) 2.81
Continued expression of a poly(A)+ transcript of herpes simplex virus type 1 in trigeminal ganglia of latently infected mice. J Virol (1987) 2.78
Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. Science (1987) 2.75
Latent ganglionic infection with herpes simplex virus types 1 and 2: viral reactivation in vivo after neurectomy. Science (1974) 2.71
Infectious virus-antibody complex in the blood of chronically infected mice. J Exp Med (1966) 2.68
Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes. Annu Rev Immunol (1989) 2.63
Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci U S A (1992) 2.48
Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression. Nat Med (1997) 2.47
IRS-2 pathways integrate female reproduction and energy homeostasis. Nature (2000) 2.45
Inhibition or enhancement of immunological injury of virus-infected cells. Proc Natl Acad Sci U S A (1971) 2.45
Prevention of cell-to-cell spread of herpes simplex virus by leukocytes. J Exp Med (1973) 2.42
Role of the nucleocapsid protein in regulating vesicular stomatitis virus RNA synthesis. Cell (1985) 2.38
Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Science (1985) 2.34
Retracted Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue. Nature (2000) 2.31
In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus. Proc Natl Acad Sci U S A (1972) 2.29
Expression of a cDNA encoding a functional 241-kilodalton vesicular stomatitis virus RNA polymerase. Proc Natl Acad Sci U S A (1985) 2.28
Comparison of direct and indirect solid-phase microradioimmunoassays for the detection of viral antigens and antiviral antibody. Appl Microbiol (1973) 2.23
Immune mechanisms by which the spread of viral infections is stopped. Cell Immunol (1974) 2.23
The development of subretinal microphotodiodes for replacement of degenerated photoreceptors. Ophthalmic Res (1997) 2.20
HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology (1991) 2.16
Polycistronic vesicular stomatitis virus RNA transcripts. Proc Natl Acad Sci U S A (1980) 2.16
Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol (1994) 2.13
Virus-induced diabetes mellitus. XVIII. Inhibition by a nondiabetogenic variant of encephalomyocarditis virus. J Exp Med (1980) 2.07
Role of matrix protein in cytopathogenesis of vesicular stomatitis virus. J Virol (1990) 2.05
The complete sequence of a unique RNA species synthesized by a DI particle of VSV. Cell (1978) 2.04
Location of the binding domains for the RNA polymerase L and the ribonucleocapsid template within different halves of the NS phosphoprotein of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1987) 2.03
Viral liposomes released from insect cells infected with recombinant baculovirus expressing the matrix protein of vesicular stomatitis virus. J Virol (1993) 2.02
Herpes simplex virus DNA and mRNA sequences in acutely and chronically infected trigeminal ganglia of mice. Virology (1978) 1.99
IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines. Cancer Res (1993) 1.96
Latent infection of sensory ganglia with herpes simplex virus: efficacy of immunization. Science (1975) 1.95
Immunological response restricts number of cells in sensory ganglia infected with herpes simplex virus. Nature (1976) 1.95
Herpes simplex virus DNA sequences in the CNS of latently infected mice. Nature (1980) 1.95
Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J Virol (1986) 1.95
Magnetic brain stimulation with a double coil: the importance of coil orientation. Electroencephalogr Clin Neurophysiol (1992) 1.91
Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality. Diabetes Care (2000) 1.91
Nucleotide sequences of eight human natural autoantibody VH regions reveals apparent restricted use of VH families. J Immunol (1989) 1.88
Terminal sequences of vesicular stomatitis virus RNA are both complementary and conserved. J Virol (1979) 1.87
Neutralization of an infectious herpes simplex virus-antibody complex by anti-gamma-globulin. Proc Natl Acad Sci U S A (1966) 1.84
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer (2008) 1.84
Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination. J Virol (1988) 1.81
Rapid micro-radioimmunoassay for the measurement of antiviral antibody. J Immunol (1972) 1.79
Virus-induced autoimmunity: monoclonal antibodies that react with endocrine tissues. Science (1983) 1.78
Latent infection of the peripheral ANS with herpes simplex virus. Nature (1975) 1.76
Intervening sequence between the leader region and the nucleopcapsid gene of vesicular stomatitis virus RNA. J Virol (1980) 1.76
Human monoclonal autoantibodies that react with multiple endocrine organs. N Engl J Med (1983) 1.73
Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis. Arthritis Rheum (1982) 1.73
Enhancement of IgE-mediated histamine release from human basophils by viruses: role of interferon. J Exp Med (1977) 1.73
Virus-induced diabetes mellitus. XX. Polyendocrinopathy and autoimmunity. J Exp Med (1981) 1.72
A specific internal RNA polymerase recognition site of VSV RNA is involved in the generation of DI particles. Cell (1979) 1.72
Elevated gamma-globulin and increased antibody production in mice infected with lactic dehydrogenase virus. J Exp Med (1966) 1.71
IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1996) 1.71
Acute and latent infection of sensory ganglia with herpes simplex virus: immune control and virus reactivation. J Gen Virol (1979) 1.71
Lymphocytes capable of making monoclonal autoantibodies that react with multiple organs are a common feature of the normal B cell repertoire. J Immunol (1984) 1.69
Virus-induced diabetes mellitus. I. Hyperglycemia and hypoinsulinemia in mice infected with encephalomyocarditis virus. J Exp Med (1973) 1.68
Homology between murine and human cellular DNA sequences and the terminal repetition of the S component of herpes simplex virus type 1 DNA. Cell (1982) 1.67
Clonal analysis of a human antibody response. II. Sequences of the VH genes of human IgM, IgG, and IgA to rabies virus reveal preferential utilization of VHIII segments and somatic hypermutation. J Immunol (1993) 1.65
A comparison of proteinpolysaccharides of bovine nasal cartilage isolated and fractionated by different methods. J Biol Chem (1970) 1.65
Multiple organ-reactive monoclonal autoantibodies. Nature (1983) 1.64
Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic beta-cells in nonobese diabetic mice. J Immunol (1994) 1.63
Neutralization of sensitized virus by purified components of complement. Proc Natl Acad Sci U S A (1970) 1.63
Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+ B cells from patients with rheumatoid arthritis. J Exp Med (1988) 1.62
The separation of new forms of the proteinpolysaccharides of bovine nasal cartilage. J Biol Chem (1966) 1.61
Prevention of ultraviolet-light-induced herpes labialis by sunscreen. Lancet (1991) 1.60
Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus. N Engl J Med (1980) 1.59
Histopathologic evaluation of proliferating cell nuclear antigen (PC10) in oral epithelial hyperplasias and premalignant lesions. Oral Surg Oral Med Oral Pathol (1994) 1.58
The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Exp Med (1999) 1.58
Regulation of hemoglobin synthesis in a murine erythroblastic leukemic cell: the requirement for replication to induce hemoglobin synthesis. Proc Natl Acad Sci U S A (1974) 1.56
In vivo transcription of the 5'-terminal extracistronic region of vesicular stomatitis virus RNA. J Virol (1981) 1.56
Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains. J Immunol (1996) 1.54
Cellular immunity to herpes simplex virus mediated by interferon. J Exp Med (1974) 1.52
Virus-induced diabetes mellitus. XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with coxsackie virus B4. J Exp Med (1978) 1.52
Identification of a second transmembrane protein tyrosine phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc Natl Acad Sci U S A (1996) 1.51
Complete sequence of the genes encoding the VH and VL regions of low- and high-affinity monoclonal IgM and IgA1 rheumatoid factors produced by CD5+ B cells from a rheumatoid arthritis patient. Int Immunol (1991) 1.50
Visual influence on human locomotion. Modulation to changes in optic flow. Exp Brain Res (1997) 1.47
F waves and motor unit size. Muscle Nerve (1992) 1.46
Efficacy of phosphonoacetic acid on herpes simplex virus infection of sensory ganglia. Infect Immun (1976) 1.45